GATA3 and mature T-cell and NK-cell non-Hodgkin lymphoma: GATA-3 expression, demonstrated by immunohistochemistry, identified a distinct subset in a multicenter cohort of PTCL, NOS patients, and was associated with inferior progression-free and overall survival.